Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€23.40
21.02.24
€46.24
21.02.25
47.01%
30.08.24

Stifel Nicolaus 
21.02.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.80
21.02.24
€46.24
21.02.25
61.23%
09:31

HC Wainwright 
21.02.24 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€7.90
20.02.24
€12.95
20.02.25
-31.30%
09:30

Jefferies Financial Group Inc. 
20.02.24 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€387.20
20.02.24
€406.87
20.02.25
16.30%
13:18

Cantor Fitzgerald 
20.02.24 50%
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€112.50
20.02.24
€129.46
20.02.25
10.74%
13:04

Cantor Fitzgerald 
20.02.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€699.00
20.02.24
€753.63
20.02.25
24.10%
13:14

Cantor Fitzgerald 
20.02.24 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€146.10
20.02.24
€198.81
20.02.25
4.17%
13:17

Cantor Fitzgerald 
20.02.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€200.60
20.02.24
€287.58
20.02.25
-7.58%
09:30

Cantor Fitzgerald 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
20.02.24
€20.35
20.02.25
-9.53%
09:30

Wells Fargo & Company 
20.02.24 50%
buy
Healthstream Inc.

Start price
Target price
Perf. (%)
€24.60
20.02.24
-
20.02.25
5.19%
30.08.24

William Blair 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€17.55
20.02.25
-10.30%
09:30

The Goldman Sachs Group, Inc. 
20.02.24 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€173.95
20.02.24
€203.21
20.02.25
-4.35%
12:43

Piper Sandler 
20.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.40
20.02.24
€217.07
20.02.25
73.44%
09:30

Royal Bank of Canada 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€16.63
20.02.25
-10.30%
09:30

Piper Sandler 
20.02.24 50%
buy
Molina Healthcare

Start price
Target price
Perf. (%)
€371.00
20.02.24
€424.95
20.02.25
-14.56%
09:30

Truist Financial Co. 
20.02.24 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€25.20
20.02.24
€73.90
20.02.25
-20.63%
09:30

Oppenheimer Holdings Inc. 
20.02.24 50%
buy
LivaNova plc

Start price
Target price
Perf. (%)
€48.00
20.02.24
€64.66
20.02.25
-3.75%
30.08.24

Mizuho 
20.02.24 50%
sell
Alkermes plc

Start price
Target price
Perf. (%)
€28.00
20.02.24
€23.09
20.02.25
-7.86%
30.08.24

UBS Group AG 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€10.58
20.02.24
€31.41
20.02.25
0.05%
09:30

Chardan Capital 
20.02.24 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
19.02.24
-
19.02.25
-
19.09.23

StockNews.com 
19.02.24 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.40
19.02.24
€85.00
30.09.25
-7.06%
09:30

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 70%
sell
Trupanion Inc.

Start price
Target price
Perf. (%)
€21.20
19.02.24
-
19.02.25
83.58%
17.08.24

Risky Investment
Lokrim 
19.02.24 20%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
10.34%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
19.02.24
-
19.02.25
2.41%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%